Publication Name	World Journal of Pharmacology
Manuscript ID	33515
Country	India

Received	2017-02-14 08:58
Peer-Review Started	2017-02-15 18:58
To Make the First Decision	2017-03-06 17:49
Return for Revision	2017-03-07 14:19
Revised	2017-03-15 18:09
Second Decision	2017-04-10 18:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-17 10:08
Articles in Press	2017-04-17 10:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-26 04:52
Publish the Manuscript Online	2017-05-27 00:56

ISSN	2220-3192 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Case Report
Article Title	Tenofovir induced severe thrombocytopenia
Manuscript Source	Unsolicited Manuscript
All Author List	Mayank Jain, Joy Vargese and Jayanthi Venkatatraman
Funding Agency and Grant Number
Corresponding Author	Dr. Mayank Jain, Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Perumbakkam, Chennai 600100, India. mayank4670@rediffmail.com
Key Words	Tenofovir; Hepatitis; Thrombocytopenia
Core Tip	The present case report highlights a rare side effect of tenofovir therapy for hepatitis B infection. As the drug is commonly used in for management of hepatitis B and human immunodeficiency virus infection, the knowledge to this rare side effect would help physicians to be more watchful and improve patient management.
Publish Date	2017-05-27 00:56
Citation	Jain M, Vargese J, Venkatatraman J. Tenofovir induced severe thrombocytopenia. World J Pharmacol 2017; 6(2): 11-13
URL	http://www.wjgnet.com/2220-3192/full/v6/i2/11.htm
DOI	http://dx.doi.org/10.5497/wjp.v6.i2.11

Full Article (PDF)	WJP-6-11.pdf
Full Article (Word)	WJP-6-11.doc
Manuscript File	33515-Review.docx
Answering Reviewers	33515-Answering reviewers.pdf
Audio Core Tip	33515-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	33515-Conflict-of-interest statement.pdf
Copyright License Agreement	33515-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	33515-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	33515-Institutional review board statement.pdf
Peer-review Report	33515-Peer-review(s).pdf
Scientific Misconduct Check	33515-Scientific misconduct check.pdf
Scientific Editor Work List	33515-Scientific editor work list.pdf